Slide 1: FY24 Results (unaudited)
FY24 Results (unaudited) 28 February 2025
Slide 2: Agenda
Agenda FY24 Results 1. Overview 2. Results Highlights 3. Financials 4. Strategy & Outlook 2
Slide 3: Overview
imexHSs Overview
Slide 4: One Company with two businesses aimed at democratising access to medical imaging expertise
One Company with two businesses aimed at democratising access to medical imaging expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 4
Slide 5: Global footprint
Global footprint Software 18 countries; 518 sites 3,326 radiologists 27 distributors in 16 countries Radiology Colombia, Spain and Mexico 36 radiology centres 160+ in-house radiologists 5
Slide 6: FY24 Results Highlights
imexHs FY24 Results Highlights
Slide 7: Business Highlights
Business Highlights • The Company is focused on generating positive earnings and cashflow. • Geographic attention remains within Latin America. • Sales on plan and pipeline for both IMEXHS Cloud and Enterprise radiology solutions remains robust. • New Value Proposition major software development rem
Slide 8: FY24 Operational Highlights
FY24 Operational Highlights • Enterprise software contract renewal with • Good progress has been made with existing Colsubsidio with improved terms and pricing. software clients in extending both the scope of The 3-year software contract is expected to services and additional sites. contribute $575,
Slide 9: FY24 Operational Highlights
FY24 Operational Highlights • New radiology services contract signed with an existing customer in Colombia with expected ARR of $564,000 with improved margins. • Fourth consecutive Colombian National Police contract renewal including price and terms increases contributing new ARR of $352,000, taking
Slide 10: FY24 Financial Highlights
FY24 Financial Highlights1 Sales Revenue Annual Recurring Underlying Revenue (ARR) 3 EBITDA4 Up 34% yoy $26.5m Up 20% yoy $30.0m vs $0.2m5 in pcp Up 27% on a constant Up 24% on a constant currency basis2 currency basis $0.5m Recurring Closing cash Debt revenue 97% of total revenue $25.8m vs $2.4m at
Slide 11: FY24 Business Unit Results
FY24 Business Unit Results $M Software Radiology Corporate Total Revenue 8.9 17.6 - 26.5 Underlying 3.1 0.1 (2.7) 0.5 EBITDA ARR 9.9 20.1 - 30.0 • Software primarily relates to sales of IMEXHS Enterprise and growing IMEXHS Cloud business ➢ Revenue up 17% vs pcp ➢ ARR up 9% vs pcp • Radiology include
Slide 12: Progress in ARR
Progress in ARR ARR as at 31 December 2024 • $30.0m, up 20% vs 31 Dec-23: ➢ Software - $9.9m, up 9% vs $9.1m at 31 Dec-23; and ➢ Radiology services - $20.1m, up 26% vs $15.9m at 31 Dec-23. (1) Constant currency basis assumes that historical results at each year end are converted at the 31 Dec-24 exc
Slide 13: FY24 Financials
ime>«Hs FY24 Financials
Slide 14: Income Statement
Income Statement #039;000 FY24 FY23 Var Var % • Revenue of $26.5m, up 34% yoy and Revenue 26,450 19,669 6,781 34% 27% on a constant currency basis Other revenue 120 252 (132) (52%) • Underlying EBITDA of $0.5m up Total revenue 26,569 19,921 6,648 33% $0.3m versus pcp profit of $0.2m • One-off goodwill
Slide 15: Balance Sheet
Balance Sheet #039;000 Dec-24 Dec 23 • Closing cash balance of $2.1m at 31 Dec-24 and Cash 2,072 2,362 Net Assets of $14.5m. Trade & other receivables 6,856 6,443 • Intangible assets of $8.1m include Goodwill of Inventories 328 112 $4.6m, Software of $2.6m, $0.8m of customer Current assets 9,256 8,917
Slide 16: Summary Cash Flow
Summary Cash Flow #039;000 FY24 FY23 • Closing cash balance of $2.1m as at 31-Dec-24 vs pcp of $2.4m. Net cash (used in)/from operating activities (635) 2,610 • Revenue growth in the year consumed Net cash (used in)/from investing activities (766) (2,133) significant working capital leading to Net cash
Slide 17: Strategy & Outlook
imexHs Strategy & Outlook
Slide 18: New Value Proposition
New Value Proposition Radiologists with Superpowers 1 Product. “The most advanced, contemporary and secure radiology AI enhanced software solution.” Current status: - New multitenant cloud-native RIS developed. - Ready for ISO 27001 and 2 Customer Service & Support. HIPPA Certification. “Unparallele
Slide 19: Product and Software Updates
Product and Software Updates ● Radiology Information System ● Universal Viewer v6.3.2 Enhancements (cont.) ➢ Wide range of new features and ➢ New authentication service, standard for log functionalities developed for the enhanced storage, improvement on loading speed of iteration of AQUILA (the RIS-
Slide 20: Focus for FY25
Focus for FY25 Software Radiology Services ● Roll out the New Value Proposition ➢ Enhanced digital security: Achieve ISO ● Focus on profitability: successfully renegotiated 27001 certification key contracts with better pricing, improving ➢ Service excellence: Delivering the best margins in early 202
Slide 21: FY25 Outlook
FY25 Outlook H1 FY25 • Continuing momentum from go live of recent Key drivers for revenue and earnings contracts. • Upfront launch costs for marketing and sales for growth: New Value Software. • Annualised Recurring H2 FY25 Revenue together with current • Radiology Profit Improvement Program through
Slide 22: Q&A
Q&A
Slide 23: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 24: Disclaimer
Disclaimer Investors should be aware that certain financial measures included in this presentation are ‘non-IFRS financial information’ under ASIC Regulatory Guide 230: ‘Disclosing non-IFRS financial information’ published by ASIC and are not recognised under International Financial Reporting Standa
Slide 25: FY24 Results
FY24 Results 28 February 2025